Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) will be releasing its earnings data after the market closes on Tuesday, November 12th. Analysts expect Guardian Pharmacy Services to post earnings of $0.19 per share for the quarter. Individual that wish to listen to the company's earnings conference call can do so using this link.
GRDN stock traded up $0.34 on Tuesday, reaching $18.98. 112,837 shares of the company were exchanged, compared to its average volume of 139,719. Guardian Pharmacy Services has a 12 month low of $14.16 and a 12 month high of $20.10.
In other news, Director Thomas J. Salentine, Jr. acquired 35,714 shares of the firm's stock in a transaction dated Friday, September 27th. The stock was purchased at an average price of $14.00 per share, for a total transaction of $499,996.00. Following the completion of the acquisition, the director now directly owns 35,714 shares in the company, valued at $499,996. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link.
Several equities research analysts have recently commented on the stock. Stephens started coverage on shares of Guardian Pharmacy Services in a research note on Tuesday, October 22nd. They issued an "overweight" rating and a $21.00 target price on the stock. Raymond James assumed coverage on Guardian Pharmacy Services in a research note on Monday, October 21st. They issued an "outperform" rating and a $21.00 price target for the company. Finally, Truist Financial assumed coverage on Guardian Pharmacy Services in a research report on Monday, October 21st. They issued a "buy" rating and a $22.00 price objective for the company.
Check Out Our Latest Stock Analysis on GRDN
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Guardian Pharmacy Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardian Pharmacy Services wasn't on the list.
While Guardian Pharmacy Services currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.